Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study to Evaluate Efficacy, Safety and Pharmacokinetics of PM8002 Injection in Combination With Paclitaxel Injection as Second Line Treatment for Small Cell Lung Cancer(SCLC)

NCT05879068 is registered in ClinicalTrials.gov with Biotheus Inc. as lead sponsor.

NCT NCT05879068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05879068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study to Evaluate Efficacy, Safety and Pharmacokinetics of PM8002 Injection in Combination With Paclitaxel Injection as Second Line Treatment for Small Cell Lung Cancer(SCLC)
Lead sponsor
Biotheus Inc.
Phase
Phase 2
Overall status
Active, not recruiting
Start date
May 27, 2022
Completion date
April 30, 2026
Enrollment
99 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

sclc